We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov Menu

Temozolomide and Sorafenib in Treating Patients With Metastatic or Unresectable Melanoma

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00602576
Recruitment Status : Unknown
Verified August 2009 by National Cancer Institute (NCI).
Recruitment status was:  Active, not recruiting
First Posted : January 28, 2008
Last Update Posted : August 13, 2009
National Cancer Institute (NCI)
Information provided by:
National Cancer Institute (NCI)

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Unknown
  Estimated Primary Completion Date : March 2008
  Study Completion Date : No date given